Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 60760-836

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 60760-836). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

836-30 (Venlafaxine 60760 836 30)

Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg label showing a quantity of 30 capsules. The label includes NDC 60760-836-30, manufacturer Aurobindo Pharma USA, Inc., and packaging by St. Mary's Medical Park Pharmacy. Storage instructions specify controlled room temperature between 15°-30°C (59°-86°F).*

FDA Label Image

Figure (Venlafaxine Fig1)

A scatter plot chart depicting fold changes and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax, AUC) in various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphisms, age over 60 years, and gender differences, comparing changes relative to a reference value.*

FDA Label Image

Figure (Venlafaxine Fig2)

A scatter plot chart showing the fold change and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax, AUC) with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value with fold change values ranging approximately from 0 to 3.*

FDA Label Image

Figure (Venlafaxine Fig3)

A scatter plot chart showing the fold change and 90% confidence intervals of various analytes' pharmacokinetic parameters (Cmax and AUC) when interacting with different drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents change relative to a reference value, centered at 1.0.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride is depicted, showing the molecular arrangement including a cyclohexane ring, methoxyphenyl group, hydroxyl group, and dimethylamino substituent along with the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.